157580-39-7 Usage
Uses
Used in Pharmaceutical Industry:
(2S,4S,5R)-3-tert-butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-1,3-oxazolidine-5-carboxylic acid is used as a chiral building block for the synthesis of pharmaceutical compounds. Its unique stereochemistry and functional groups can be utilized in the development of novel drugs with improved efficacy and selectivity.
Used in Chemical Research:
(2S,4S,5R)-3-tert-butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-1,3-oxazolidine-5-carboxylic acid serves as a valuable compound for studying the synthesis and reactivity of chiral oxazolidine derivatives. Its complex structure and specific stereochemistry make it an interesting subject for research in organic chemistry and stereoselective synthesis.
Used in Material Science:
(2S,4S,5R)-3-tert-butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-1,3-oxazolidine-5-carboxylic acid can be employed as a precursor for the development of new chiral materials with potential applications in various fields, such as sensors, catalysts, and chiral separation techniques.
Note: The specific applications mentioned above are hypothetical and based on the general properties of similar compounds. Further research and experimentation would be required to confirm the actual uses and benefits of (2S,4S,5R)-3-tert-butoxycarbonyl-2-(4-methoxyphenyl)-4-phenyl-1,3-oxazolidine-5-carboxylic acid in these industries.
Check Digit Verification of cas no
The CAS Registry Mumber 157580-39-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,7,5,8 and 0 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 157580-39:
(8*1)+(7*5)+(6*7)+(5*5)+(4*8)+(3*0)+(2*3)+(1*9)=157
157 % 10 = 7
So 157580-39-7 is a valid CAS Registry Number.
157580-39-7Relevant academic research and scientific papers
Synthetic method of docetaxel side chain
-
, (2021/03/31)
The invention relates to a synthetic method of a docetaxel side chain, which comprises the following steps: by using (2R, 3S)-2-hydroxy-3-phenyl-3-(((S)-1-phenethyl)-amino)methyl propionate as a raw material, carrying out reduction reaction in the presence of palladium on carbon and hydrogen to obtain (2R, 3S)-3-phenyl isoserine methyl ester salt, and carrying out di-tert-butyl dicarbonate substitution reaction to obtain (2R, 3S)-3-t-butyloxycarboryl-2-hydroxy-3-Methyl 3-phenylpropionate; preparing (4S, 5R)-3-tert-butoxycarbonyl-2-(4-methoxy phenyl)-4-phenyl-5-oxazoline carboxylic acid methylester from through cyclization protection reaction, and finally hydrolyzing to obtain a docetaxel side chain crude product; and recrystallizing the crude product of the docetaxel side chain, and further purifying to obtain a finished product of the docetaxel side chain. The synthetic method disclosed by the invention is safe, environment-friendly, economical, efficient and suitable for large-scaleindustrial production.
